This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Denali Therapeutics Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Melina Lenser: Innovator in Protein Therapeutics
Introduction
Melina Lenser is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of protein therapeutics, particularly in the treatment of rare diseases. Her innovative work focuses on developing proteins that can effectively cross the blood-brain barrier.
Latest Patents
Melina holds 1 patent for her invention titled "Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof." This patent describes proteins capable of being transported across the blood-brain barrier and includes an acid alpha-glucosidase (GAA) enzyme-Fc fusion polypeptide. The methods outlined in her patent aim to treat Pompe disease, a rare genetic disorder.
Career Highlights
Melina is currently employed at Denali Therapeutics Inc., where she continues to advance her research in protein therapeutics. Her work is pivotal in developing treatments that can improve the quality of life for patients suffering from neurological conditions.
Collaborations
Melina collaborates with esteemed colleagues, including Mihalis S Kariolis and Cathal S Mahon, who contribute to her research efforts and innovations in the field.
Conclusion
Melina Lenser's contributions to protein therapeutics exemplify the impact of innovative research on treating complex diseases. Her work not only advances scientific knowledge but also holds the potential to transform patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile